Outlook of the global enteric disease testing market
Technavio’s market research analyst predicts the global enteric disease testing market to grow steadily at a CAGR of around 9% during the forecast period. Recently, it has been observed that enteric diseases, such as diarrhea, cholera, and typhoid fever, are on the rise among the global population. Consequently, vendors and academics have developed an isothermal nucleic acid amplification-based diagnostic method, which incorporates all the temperature dependent steps of PCR by utilizing enzymes. Since this technology is highly specific and sensitive, healthcare facilities from across the globe can use this method to rapidly diagnose and detect pathogens. The ability of this technology to efficiently identify pathogens without the use of a thermocycler will result in this market’s impressive growth during the forecast period.
In terms of geography, the Americas accounted for about 50% of the total market share in 2015 and is envisaged to grow steadily at a CAGR of around 6% during the forecast period. Factors such as the high demand for molecular diagnostic tests and the high level of enteric disease awareness among the population will spur market growth in this region until 2020.
Disease-based segmentation of the enteric disease testing market
- Bacterial enteric diseases
- Viral enteric diseases
The bacterial enteric disease segment currently dominates this market and accounts for a market share of approximately 80% during the forecast period. The high prevalence of GI diseases, such as diarrhea and typhoid fever, will fuel the demand for bacterial enteric disease testing among patients during the forecast period.
Segmentation by type of clinical diagnosis and analysis of the enteric disease testing market
- Immunoassay testing
- Conventional testing
- Molecular diagnostic testing
In this market study, analysts have observed that the immunoassay testing segment accounted for a market share of around 50% in 2015. The high portability and quick turnaround time of immunoassay testing will lead to its augmented adoption during the forecast period. Additionally, its ability to test samples near the site of patient care will foster its utilization until the end of 2020.
Competitive landscape and key vendors
The global enteric disease testing market is highly fragmented due to the presence of small and medium-sized vendors that provide enteric disease testing products. The emerging economies such as China, India, and Brazil represent new opportunities for vendors to launch their enteric disease test instrument and test kits. The vendors that have the capability to offer a comprehensive portfolio of products, based on different technologies, to meet the needs of end users are expected to gain maximum market traction during the forecast period.
The leading vendors in the market are -
- Alere
- bioMérieux
- Cepheid
- DiaSorin
Other prominent vendors in the market include BD, Biomerica, Coris BioConcept, Meridian Bioscience, Mobidiag, Quest Diagnostics, R-Biopharm, Trinity Biotech, and Thermo Fisher Scientific
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the global enteric disease testing market?
- What are the key market trends impacting the growth of the enteric disease testing market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the vendors in the global enteric disease testing market?
- What are the trending factors influencing the market shares of the Americas, APAC, Europe, and MEA?
- What are the key outcomes of the five forces analysis of the enteric disease testing market?
Technavio also offers customization on reports based on specific client requirement.
Related reports: